Peptides DB
Research-centric peptide and protocol reference hub
Study 13 of 15Melanotan II literatureCell metabolismTop journal2025

Leptin enhances the intracellular thyroid hormone activation in skeletal muscle to boost energy balance.

Not reported in abstract.

Read at Cell metabolismAdd to compare

Where it sits

this study against the rest of the melanotan ii corpus
5
Preclinical · this one
9
Observational
0
Open-label
1
Randomised
0
Reviews

Summary and findings

Not reported in abstract.

How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2025

Abstract

The authors’ words, as Cell metabolism supplied them

Thyroid hormones (THs) are key modulators of energy metabolism and cross-talk with other endocrine and metabolic factors. Notably, leptin can increase hypothalamic control of TH synthesis as an adaptive metabolic response regulating body weight. In this study, we found that the TH signal is heightened in overweight humans and is lost with obesity. In mice, systemic and intracerebroventricular leptin injection induces the expression of type 2 deiodinase (D2), the TH-activating enzyme, in skeletal muscle. Mechanistically, leptin enhances the transcription of D2 by a STAT3- and α-melanocyte-stimulating hormone (α-MSH)/cyclic AMP (cAMP)-dependent regulation. Notably, mice lacking D2 or with a mutation in the TH receptor do not exhibit the metabolic effects of leptin, such as increased insulin sensitivity and oxygen consumption, indicating that leptin's peripheral metabolic effects in skeletal muscle are mediated by TH. These findings underscore the critical role of leptin in integrating the TH-induced metabolic activation, while also contributing to appetite suppression in response to perceived fat stores.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the Melanotan II corpus

DControlling mountain-type zoonotic visceral leishmaniasis in China: Current progress and challenges through a One Health lens.One health (Amsterdam, Netherlands) · 2026 · Average total score was 47.77/100 (range: 38.59-61.72).reviewDDirect photoreception by pituitary endocrine cells regulates hormone release and pigmentation.Science (New York, N.Y.) · 2025ATebentafusp (IMCgp100), a first in class immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) for HLA-A*02:01 positive uveal melanoma: Product review.Human vaccines & immunotherapeutics · 2026 · Not reported in abstract.reviewBIntegrative multi-omics Mendelian randomization reveals key lipid metabolism genes as therapeutic targets for diabetic nephropathy pathogenesis.Renal failure · 2026 · n=100000 · CERS2: OR = 1.246, p_SMR = 0.027reviewBAssessing nutritional risk and its association with mortality in ICU patients using the modified NUTRIC score: evidence from a tertiary care hospital.Annals of medicine · 2026 · n=584 · Adjusted odds ratio for low nutritional risk associated with mortality was 0.51 (95% CI 0.28-0.91).HumanCAssociation of central α-klotho with dopaminergic and melanocortin receptors on feed intake regulation in chicken.europepmc · 2026 · Not reported in abstract.Animal